Cargando…

Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database Analysis

AIMS: Two complementary studies were used to assess the real-life use of nalmefene in alcohol-dependent patients and its impact on alcohol use health status. METHODS: USE-PACT was a prospective cohort study designed to evaluate the real-life effectiveness of nalmefene in the management of alcohol de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aubin, Henri-Jean, Dureau-Pournin, Caroline, Falissard, Bruno, Paille, François, Rigaud, Alain, Micon, Sophie, Pénichon, Marine, Andersohn, Frank, Truchi, Christine, Blin, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406069/ https://www.ncbi.nlm.nih.gov/pubmed/33969378 http://dx.doi.org/10.1093/alcalc/agab029

Ejemplares similares

Corrigendum to: Use of Nalmefene in Routine Practice: Results from a French Prospective Cohort Study and a National Database Analysis
por: Aubin, Henri-Jean, et al.
Publicado: (2021)

Nalmefene: a new approach to the treatment of alcohol dependence
por: Paille, François, et al.
Publicado: (2014)

Secondary prevention of acute coronary syndrome with antiplatelet agents in real life: A high-dimensional propensity score matched cohort study in the French National claims database
por: Blin, Patrick, et al.
Publicado: (2020)

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
por: Blin, P., et al.
Publicado: (2012)

Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
por: Luquiens, Amandine, et al.
Publicado: (2014)

A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC
por: Blin, Patrick, et al.
Publicado: (2015)

Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database
por: Blin, Patrick, et al.
Publicado: (2021)

The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients
por: François, Clément, et al.
Publicado: (2015)

Off-Label Baclofen Prescribing Practices among French Alcohol Specialists: Results of a National Online Survey
por: Rolland, Benjamin, et al.
Publicado: (2014)

Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies
por: Chick, Jonathan, et al.
Publicado: (2021)

Evaluation in alcohol use disorders – insights from the nalmefene experience
por: Naudet, Florian, et al.
Publicado: (2016)

Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?
por: Braillon, Alain, et al.
Publicado: (2015)

In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene
por: Xie, Xiangyang, et al.
Publicado: (2015)

Nalmefene: a new approach to the treatment of alcohol dependence [Corrigendum]
Publicado: (2015)

Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation: A Population-Based New Users High-Dimensional Propensity Score Matched Cohorts Study
por: Blin, Patrick, et al.
Publicado: (2019)

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
por: van den Brink, Wim, et al.
Publicado: (2013)

Drinking Levels and Profiles of Alcohol Addicted Rats Predict Response to Nalmefene
por: Foo, Jerome Clifford, et al.
Publicado: (2019)

Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
por: Higuchi, Susumu, et al.
Publicado: (2020)

Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
por: Roerecke, Michael, et al.
Publicado: (2015)

Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
por: Fitzgerald, Niamh, et al.
Publicado: (2016)

Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial
por: Miyata, Hisatsugu, et al.
Publicado: (2019)

The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV Trial
por: Barrio, Pablo, et al.
Publicado: (2019)

Effect of Sufentanil Combined with Nalmefene Assisted Surface Anesthesia on Transnasal Endotracheal Intubation Guided by Fiberoptic Bronchoscope
por: Zhao, Zhanqi, et al.
Publicado: (2022)

The efficacy of nalmefene on anesthetic recovery of patients: a study protocol for a multicenter randomized controlled trial
por: Ma, Xiaowen, et al.
Publicado: (2023)

French-language version of the World Health Organization quality of life spirituality, religiousness and personal beliefs instrument
por: Mandhouj, Olfa, et al.
Publicado: (2012)

Apoptotic Effect of Morphine, Imiquimod and Nalmefene on Promastigote, Infected and Uninfected Macrophages with Amastigote of Leishmania Major by Flow Cytometry
por: Ebrahimisadr, Parisa, et al.
Publicado: (2018)

Behandlung dissoziativer Symptome mit Nalmefen bei Patienten mit Borderline-Persönlichkeitsstörung und komplexer posttraumatischer Belastungsstörung
por: Enning, Frank, et al.
Publicado: (2021)

The effects of nalmefene on the impulsive and reflective system in alcohol use disorder: A resting-state fMRI study
por: Grundinger, Nadja, et al.
Publicado: (2022)

Low-dose nalmefene pretreatment reduces etomidate-induced myoclonus: A randomized, double-blind controlled trial
por: Shan, Guofa, et al.
Publicado: (2023)

Retracted: Effect of Sufentanil Combined with Nalmefene Assisted Surface Anesthesia on Transnasal Endotracheal Intubation Guided by Fiberoptic Bronchoscope
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Prevalence of mental disorders in French prisons for men
por: Falissard, Bruno, et al.
Publicado: (2006)

Are social norms associated with smoking in French university students? A survey report on smoking correlates
por: Riou França, Lionel, et al.
Publicado: (2009)

Peer substance use overestimation among French university students: a cross-sectional survey
por: Riou Franca, Lionel, et al.
Publicado: (2010)

Are social norms associated with smoking in French university students? A survey report on smoking correlates
por: Riou França, Lionel, et al.
Publicado: (2009)

Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’
por: Higuchi, Susumu, et al.
Publicado: (2020)

Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder
por: Karl, Damian, et al.
Publicado: (2021)

Sufentanil combined with nalmefene reduce the adverse events in recovery period of patients undergoing uvulopalatopharyngoplasty – A randomized controlled trial
por: Wang, Jin, et al.
Publicado: (2023)

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
por: Palpacuer, Clément, et al.
Publicado: (2015)

The French Observational Cohort of Usual Smokers (FOCUS) cohort: French smokers perceptions and attitudes towards smoking cessation
por: Aubin, Henri-Jean, et al.
Publicado: (2010)

Evaluation of Morphine with Imiquimod as Opioid Growth Factor Receptor or Nalmefene as Opioid Blocking Drug on Leishmaniasis Caused by Leishmania major in Vitro
por: JABARI, Javad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jqf79p655g3getc5lvs8dbpf1q